Page last updated: 2024-08-23

phenyl acetate and Dyslipidemias

phenyl acetate has been researched along with Dyslipidemias in 13 studies

Research

Studies (13)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (15.38)29.6817
2010's10 (76.92)24.3611
2020's1 (7.69)2.80

Authors

AuthorsStudies
Zucchi, R1
Chen, H; Olatunji, OJ; Zhou, Y1
Aiyer, A; Asp, P; Barahman, M; Beck, AP; Guha, C; Harris, HY; Kabarriti, R; Kinkhabwala, M; Roy-Chowdhury, J; Roy-Chowdhury, N; Scanlan, TS; Zhang, W1
Abdallah, M; Abi Rafeh, N; Bhat, T; El-Sayegh, S; Kalantar-Zadeh, K; Khoueiry, G; Lafferty, J; Raza, M; Saiful, F1
Chew, GT; Sahebkar, A; Watts, GF1
Lammel Lindemann, J; Webb, P1
Gotto, AM; Pownall, HJ1
Eller, P; Patsch, JR; Ritsch, A; Tancevski, I1
Cioffi, F; Goglia, F; Lanni, A1
Demetz, E; Eller, P; Tancevski, I1
Bateman, K; Chan, CC; Huang, Z; Landry, F; Leclair, G; Li, CS; Oballa, R; Zhang, L1
Choi, YJ; Geaney, JC; Karpf, DB; Krauss, RM; Naim, S; Roberts, BK; Wang, X; Wojnoonski, K1
Berry, C; Grégoire, J; Ibrahim, R; L'Allier, PL; Lespérance, J; Levesque, S; Tardif, JC1

Reviews

7 review(s) available for phenyl acetate and Dyslipidemias

ArticleYear
Thyroid Hormone Analogues: An Update.
    Thyroid : official journal of the American Thyroid Association, 2020, Volume: 30, Issue:8

    Topics: Acetates; Anilides; Animals; Central Nervous System Diseases; Clinical Trials as Topic; Diiodothyronines; Drug Design; Dyslipidemias; Humans; Liver Diseases; Male; Mice; Mutation; Non-alcoholic Fatty Liver Disease; Phenols; Pyridazines; Rats; Signal Transduction; Thyroid Hormone Receptors alpha; Thyroid Hormone Receptors beta; Thyroid Hormones; Thyronines; Triiodothyronine; Uracil

2020
High-density lipoprotein in uremic patients: metabolism, impairment, and therapy.
    International urology and nephrology, 2014, Volume: 46, Issue:1

    Topics: Acetamides; Acetates; Acetyl-CoA C-Acetyltransferase; Anti-Inflammatory Agents; Anticholesteremic Agents; Antioxidants; Apolipoprotein A-I; Atherosclerosis; Cholesterol; Cholesterol Ester Transfer Proteins; Dyslipidemias; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Lipoproteins, HDL; Niacin; PPAR alpha; Quinolines; Renal Insufficiency, Chronic; Sulfonamides; Sulfonic Acids; Uremia

2014
New peroxisome proliferator-activated receptor agonists: potential treatments for atherogenic dyslipidemia and non-alcoholic fatty liver disease.
    Expert opinion on pharmacotherapy, 2014, Volume: 15, Issue:4

    Topics: Acetates; Animals; Atherosclerosis; Chalcones; Cholesterol, HDL; Dyslipidemias; Fatty Liver; Fenofibrate; Humans; Insulin Resistance; Lipoproteins, HDL; Non-alcoholic Fatty Liver Disease; Peroxisome Proliferator-Activated Receptors; Propionates; Quinolines; Sulfonamides; Thiazoles; Triazoles; Triglycerides

2014
New Insights into the High-Density Lipoprotein Dilemma.
    Trends in endocrinology and metabolism: TEM, 2016, Volume: 27, Issue:1

    Topics: Acetates; Alcohols; Animals; Atherosclerosis; Cardiovascular Diseases; Dyslipidemias; Humans; Lipoproteins, HDL; Receptors, G-Protein-Coupled

2016
The resurgence of thyromimetics as lipid-modifying agents.
    Current opinion in investigational drugs (London, England : 2000), 2009, Volume: 10, Issue:9

    Topics: Acetates; Anilides; Animals; Anticholesteremic Agents; Arteriosclerosis; Atherosclerosis; Biological Transport; Biomimetics; Cholesterol, LDL; Clinical Trials as Topic; Dyslipidemias; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Lipid Metabolism; Malonates; Molecular Structure; Organophosphonates; Phenols; Phenyl Ethers; Phenylacetates; Propionates; Pyridazines; Receptors, LDL; Thyroid Gland; Thyroid Hormones

2009
Thyroid hormones, mitochondrial bioenergetics and lipid handling.
    Current opinion in endocrinology, diabetes, and obesity, 2010, Volume: 17, Issue:5

    Topics: Acetates; Adiposity; Anilides; Animals; Atherosclerosis; Cardiovascular Diseases; Clinical Trials as Topic; Diiodothyronines; Dyslipidemias; Energy Metabolism; Fatty Liver; Humans; Lipid Metabolism; Mice; Mitochondria; Obesity; Phenols; Rats; Thyroid Hormones

2010
Sobetirome: a selective thyromimetic for the treatment of dyslipidemia.
    Recent patents on cardiovascular drug discovery, 2011, Volume: 6, Issue:1

    Topics: Acetates; Animals; Bile Acids and Salts; Biomarkers; Cholesterol; Dyslipidemias; Humans; Hypolipidemic Agents; Liver; Molecular Mimicry; Phenols; Receptors, LDL; Thyroid Hormones; Treatment Outcome; Triglycerides

2011

Trials

1 trial(s) available for phenyl acetate and Dyslipidemias

ArticleYear
Effects of the PPAR-δ agonist MBX-8025 on atherogenic dyslipidemia.
    Atherosclerosis, 2012, Volume: 220, Issue:2

    Topics: Acetates; Analysis of Variance; Atherosclerosis; Atorvastatin; Biomarkers; Chi-Square Distribution; Double-Blind Method; Drug Therapy, Combination; Dyslipidemias; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Lipoproteins; Male; Middle Aged; Obesity; Overweight; Particle Size; PPAR gamma; Pyrroles; Time Factors; Treatment Outcome; Triazoles

2012

Other Studies

5 other study(ies) available for phenyl acetate and Dyslipidemias

ArticleYear
Effect of the Polyphenol Rich Ethyl Acetate Fraction from the Leaves of Lycium chinenseMill. on Oxidative Stress, Dyslipidemia, and Diabetes Mellitus in Streptozotocin-Nicotinamide Induced Diabetic Rats.
    Chemistry & biodiversity, 2017, Volume: 14, Issue:10

    Topics: Acetates; Animals; Blood Glucose; Body Weight; Diabetes Mellitus, Experimental; Dyslipidemias; Lycium; Male; Niacinamide; Oxidative Stress; Plant Leaves; Polyphenols; Rats; Rats, Sprague-Dawley; Streptozocin

2017
Radiation-primed hepatocyte transplantation in murine monogeneic dyslipidemia normalizes cholesterol and prevents atherosclerosis.
    Journal of hepatology, 2019, Volume: 70, Issue:6

    Topics: Acetates; Animals; Apolipoproteins E; Atherosclerosis; Cholesterol; Disease Models, Animal; Dyslipidemias; Female; Hepatocytes; Hyperlipoproteinemia Type II; Male; Mice; Mice, Inbred C57BL; Phenols

2019
Sobetirome: the past, present and questions about the future.
    Expert opinion on therapeutic targets, 2016, Volume: 20, Issue:2

    Topics: Acetates; Animals; Cardiovascular Diseases; Cholesterol; Clinical Trials as Topic; Dogs; Dyslipidemias; Humans; Liver; Phenols; Thyroid Hormone Receptors beta

2016
Plasma-based approach to measure target engagement for liver-targeting stearoyl-CoA desaturase 1 inhibitors.
    Journal of lipid research, 2011, Volume: 52, Issue:8

    Topics: Acetates; Animals; Biological Assay; Carbon Radioisotopes; Chromatography, High Pressure Liquid; Deuterium; Diabetes Mellitus; Dyslipidemias; Enzyme Inhibitors; Humans; Liver; Male; Mass Spectrometry; Molecular Targeted Therapy; Oleic Acid; Plasma; Rats; Rats, Sprague-Dawley; Stearoyl-CoA Desaturase; Tetrazoles

2011
Comparison of intravascular ultrasound and quantitative coronary angiography for the assessment of coronary artery disease progression.
    Circulation, 2007, Apr-10, Volume: 115, Issue:14

    Topics: Acetamides; Acetates; Aged; Atherosclerosis; Biomarkers; Cineangiography; Coronary Angiography; Coronary Artery Disease; Disease Progression; Drug Therapy, Combination; Dyslipidemias; Endothelium, Vascular; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Image Processing, Computer-Assisted; Male; Middle Aged; Multicenter Studies as Topic; Myocardial Infarction; Randomized Controlled Trials as Topic; Sterol O-Acyltransferase; Sulfonamides; Sulfonic Acids; Ultrasonography, Interventional

2007